ArticlePloS one2026

Economic and organizational impact of oral versus intravenous and subcutaneous administration of hypomethylating agents in patients with acute myeloid leukemia not eligible for intensive chemotherapy in Spain.

María Lloret Avellá et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.